UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Implementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian Center

Scientific reports, 2020-12, Vol.10 (1), p.21481-21481, Article 21481

2020

Volltextzugriff (PDF)

Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions

The American journal of pathology, 2010-03, Vol.176 (3), p.1169-1180

2010

Volltextzugriff (PDF)

Bioanalysis of doxorubicin aglycone metabolites in human plasma samples–implications for doxorubicin drug monitoring

Scientific reports, 2020-10, Vol.10 (1), p.18562-18562, Article 18562

2020

Volltextzugriff (PDF)

Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia

Haematologica (Roma), 2022-01, Vol.107 (1), p.49-57

2022

Volltextzugriff (PDF)

A comparison of genotyping arrays

European journal of human genetics : EJHG, 2021-11, Vol.29 (11), p.1611-1624

2021

Volltextzugriff (PDF)

Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models

PloS one, 2015-11, Vol.10 (11), p.e0142612-e0142612

2015

Volltextzugriff (PDF)

Inhibitors of histone deacetylases as potential therapeutic tools for high‐risk embryonal tumors of the nervous system of childhood

International journal of cancer, 2007-04, Vol.120 (8), p.1787-1794

2007

Volltextzugriff (PDF)

Therapeutic drug monitoring of asparaginase in the ALL-BFM 2000 protocol between 2000 and 2007

Pediatric blood & cancer, 2010-07, Vol.54 (7), p.952-958

2010

Volltextzugriff (PDF)

Population Pharmacokinetics of Liposomal Amphotericin B and Caspofungin in Allogeneic Hematopoietic Stem Cell Recipients

Antimicrobial Agents and Chemotherapy, 2012-01, Vol.56 (1), p.536-543

2012

Volltextzugriff (PDF)

A population pharmacokinetic model for pegylated‐asparaginase in children

British journal of haematology, 2010-01, Vol.148 (1), p.119-125

2010

Volltextzugriff (PDF)

Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure

BMC pharmacology & toxicology, 2020-05, Vol.21 (1), p.37-10, Article 37

2020

Volltextzugriff (PDF)

Randomized Comparison of Safety and Pharmacokinetics of Caspofungin, Liposomal Amphotericin B, and the Combination of Both in Allogeneic Hematopoietic Stem Cell Recipients

Antimicrobial Agents and Chemotherapy, 2010-10, Vol.54 (10), p.4143-4149

2010

Volltextzugriff (PDF)

Five-year single-center study of asparaginase therapy within the ALL-BFM 2000 trial

Pediatric blood & cancer, 2011-09, Vol.57 (3), p.378-384

2011

Volltextzugriff (PDF)

No evidence of increased asparagine levels in the bone marrow of patients with acute lymphoblastic leukemia during asparaginase therapy

Pediatric blood & cancer, 2013-02, Vol.60 (2), p.258-261

2013

Volltextzugriff (PDF)

Asparaginase pharmacology: challenges still to be faced

Cancer Chemotherapy and Pharmacology, 2017-03, Vol.79 (3), p.439-450

Lanvers-Kaminsky, Claudia

2017

Volltextzugriff (PDF)

Cytotoxicity of Dimethylacetamide and Pharmacokinetics in Children Receiving Intravenous Busulfan

Journal of clinical oncology, 2007-05, Vol.25 (13), p.1772-1778

2007

Volltextzugriff (PDF)

Association of telomerase activity with radio- and chemosensitivity of neuroblastomas

Radiation oncology (London, England), 2010-07, Vol.5 (1), p.66-66, Article 66

2010

Volltextzugriff (PDF)

Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin

Pharmacogenomics, 2017-12, Vol.18 (18), p.1683-1695

2017

Volltextzugriff (PDF)

Cytotoxicity of treosulfan and busulfan on pediatric tumor cell lines

Anti-cancer drugs, 2006-07, Vol.17 (6), p.657-662

2006

Volltextzugriff (PDF)

An in-vitro evaluation of the polo-like kinase inhibitor GW843682X against paediatric malignancies

Anti-cancer drugs, 2011-07, Vol.22 (6), p.531-542

2011

Volltextzugriff (PDF)

Preclinical Evaluation of Combined Topoisomerase and Proteasome Inhibition Against Pediatric Malignancies

Anticancer research, 2018-07, Vol.38 (7), p.3977-3984

2018

Volltextzugriff (PDF)

A Population Pharmacokinetic Model Describing the Activity-Time-Course of PEG-Asparaginase in Children

Blood, 2004-11, Vol.104 (11), p.2746-2746

2004

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(57)
Buchkapitel
(2)

Sprache

Englisch
(59)

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Life Sciences & Biomedicine
(45)
Humans
(40)
Child
(22)
Oncology
(22)
Pharmacology & Pharmacy
(20)
Adolescent
(16)
Child, Preschool
(16)
Male
(16)
Cell Line, Tumor
(15)
Female
(15)
Biological And Medical Sciences
(13)
Hematology
(13)
Medical Sciences
(13)
Infant
(11)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Drug Therapy
(11)
Adult
(9)
Neoplasms - Drug Therapy
(9)
Asparaginase - Therapeutic Use
(8)
Cisplatin
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Implementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian Center

Incidence and Characteristics of Hypersensitivity Reactions to PEG‐asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP‐BFM ALL 2009 Study Protocol

Hypersensitivity Reactions to Native E. coli L‐asparaginase in Children With Acute Lymphoblastic Leukemia Treated in Trial ALL‐BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction

Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions

Bioanalysis of doxorubicin aglycone metabolites in human plasma samples–implications for doxorubicin drug monitoring

Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia

A comparison of genotyping arrays

Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models

Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study

Inhibitors of histone deacetylases as potential therapeutic tools for high‐risk embryonal tumors of the nervous system of childhood

Therapeutic drug monitoring of asparaginase in the ALL-BFM 2000 protocol between 2000 and 2007

Population Pharmacokinetics of Liposomal Amphotericin B and Caspofungin in Allogeneic Hematopoietic Stem Cell Recipients

A population pharmacokinetic model for pegylated‐asparaginase in children

Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure

Randomized Comparison of Safety and Pharmacokinetics of Caspofungin, Liposomal Amphotericin B, and the Combination of Both in Allogeneic Hematopoietic Stem Cell Recipients

Five-year single-center study of asparaginase therapy within the ALL-BFM 2000 trial

No evidence of increased asparagine levels in the bone marrow of patients with acute lymphoblastic leukemia during asparaginase therapy

Asparaginase pharmacology: challenges still to be faced

Cytotoxicity of Dimethylacetamide and Pharmacokinetics in Children Receiving Intravenous Busulfan

Association of telomerase activity with radio- and chemosensitivity of neuroblastomas

Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin

Cytotoxicity of treosulfan and busulfan on pediatric tumor cell lines

An in-vitro evaluation of the polo-like kinase inhibitor GW843682X against paediatric malignancies

Preclinical Evaluation of Combined Topoisomerase and Proteasome Inhibition Against Pediatric Malignancies

A Population Pharmacokinetic Model Describing the Activity-Time-Course of PEG-Asparaginase in Children

Aktive Filter

Suchergebnisse filtern